drugset / Trial / NCT05773586
A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918.
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics and efficacy of APG-5918 in Healthy Subjects or Anemic Patients.
Timeline
- Start
- 2023-03-13
- Primary completion
- 2027-12-31
- Completion
- 2028-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | APG-5918 | Unknown | 10 mg | Oral |
| Subject | APG-5918 | Unknown | 50 mg | Oral |
| Subject | APG-5918 | Unknown | 200 mg | Oral |